From the Wall Street Journal Health Blog:
Drug and device companies, along with other industry players, spend about $1 billion a year to fund the continuing medical education classes doctors have to take to keep their licenses current. We may soon get more insight into how that money flows: A little-discussed provision in the House health care bill would require drug makers to disclose their spending on CME, the WSJ reports.
Sens. Herb Kohl and Chuck Grassley have been interested in this sort of thing for a while — and they’ve been the target of some critical blog posts by Tom Sullivan, the owner of a CME company called Rockpointe.
Filed under: Uncategorized





